Annual Decline in Pentraxin 3 Is a Risk of Vascular Access Troubles in Hemodialysis Patients

Table 3

Cox-regression models for the incidence of vascular access troubles with or without multivariable adjustment.

	Unadjusted			Adjusted by DM, sex,; age, dialysis-period, and BMI
	Hazard ratio	95% C.I.	value	Hazard ratio	95% C.I.	value
Baseline PTX3	1.006	0.836–1.211	0.951	1.237	0.936–1.635	0.136
PTX3	0.849	0.680–1.061	0.151	0.732	0.544–0.985	0.03
Baseline hsCRP	3.644	0.469–28.30	0.216	2.713	0.389–18.92	0.314
hsCRP	9.486	0.108–833.2	0.324	3.605	0.033–394.7	0.592

The incidence of vascular access troubles during follow-up years was set as the outcome. Covariants examined in Table 2 were used for adjustment. < 0.05. C.I.: confidential intervals, PTX3: annual change in pentraxin 3 (ng/mL per year), and ΔhsCRP: annual change in high-sensitivity C-reactive protein (mg/dL per year).